Gavi and the UK can turn a new page together

13 August 2024

An Expert View from  the new chief executive of Gavi, the Vaccine Alliance, Sania Nishtar.

The last time there was a transition of power in the UK to the Labour Party was 27 years ago in 1997. Gavi, the Vaccine Alliance, did not yet exist. Globally, that year more than 10 million children under-five died from vaccine-preventable diseases like pneumonia, diarrhoea and measles – double the number of deaths of children under-five that we see today. And there were more than 5,000 cases of wild poliovirus recorded in 50 countries in 1997, compared with a handful of cases restricted to just two countries today.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Company Spotlight



More Features in Pharmaceutical